NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER)
Clinical trials for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) explained in plain language.
Never miss a new study
Get alerted when new NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) trials appear
Sign up with your email to follow new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat lung cancer: Two-Drug attack aims to shrink tumors
Disease control Not yet recruitingThis study is testing whether combining an older chemotherapy drug (gemcitabine) with a newer two-target drug (ivonescimab) can help control advanced non-small cell lung cancer that has gotten worse despite standard treatment. It will involve about 47 adults whose cancer has prog…
Matched conditions: NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER)
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New dosing strategy aims to fight lung Cancer's spread to the brain
Disease control Not yet recruitingThis study is testing if taking a higher dose of the lung cancer drug furmonertinib every other day is more effective and safe for patients whose cancer has spread to the lining of the brain and spinal cord. It will enroll 42 adults with a specific genetic mutation (EGFR) whose c…
Matched conditions: NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER)
Phase: NA • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New approach aims to make tough lung cancer treatment more tolerable
Disease control Not yet recruitingThis study is testing whether a comprehensive prevention plan can help Chinese patients with advanced lung cancer better tolerate treatment with the drug amivantamab. The plan aims to reduce common side effects like skin rash, infusion reactions, and blood clots. Researchers will…
Matched conditions: NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER)
Phase: PHASE4 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New 'Sandwich' treatment aims to shrink tumors faster, protect lungs
Disease control Not yet recruitingThis study is testing a new combination of radiation and drug therapy for people with advanced non-small cell lung cancer (NSCLC). Researchers want to see if a new 'high-low' radiation dose strategy, given after two cycles of chemotherapy and immunotherapy drugs, can shrink tumor…
Matched conditions: NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 23, 2026 15:28 UTC
-
Double attack on lingering lung cancer cells after surgery
Disease control Not yet recruitingThis study is for people with advanced lung cancer who had chemotherapy and immunotherapy before surgery, but cancer cells were still found in their lymph nodes after the operation. It tests whether adding a targeted radiation treatment to the standard immunotherapy drug helps ke…
Matched conditions: NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER)
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope for tough lung cancer cases: trial targets brain tumors after standard drugs fail
Disease control Not yet recruitingThis study is testing whether adding a new drug called sac-TMT to a standard lung cancer pill, with or without brain radiation, can help control cancer that has spread to the brain after other similar pills have stopped working. It will involve about 45 adults with a specific typ…
Matched conditions: NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER)
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Can a lung cancer drug still fight back after failing?
Disease control Not yet recruitingThis study looks back at medical records to see if continuing the drug anlotinib helps control advanced lung cancer, even after the cancer has started growing again. It will include about 350 people with specific types of lung cancer who kept taking anlotinib or switched to other…
Matched conditions: NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER)
Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Scientists search for clues in lung cancer tumors
Knowledge-focused Not yet recruitingThis study aims to understand how immune system markers in tumor samples relate to treatment response in advanced lung cancer patients receiving standard immunochemotherapy. Researchers will analyze small tumor samples collected before treatment, during treatment, and if the canc…
Matched conditions: NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER)
Sponsor: Technische Universität Dresden • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC